Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries with Bladder Cancer: A SEER-Medicare Analysis
To determine the rate and determinants of neoadjuvant chemotherapy non-completion in patients with muscle-invasive bladder cancer.
Source: Urology - Category: Urology & Nephrology Authors: Lee A Hugar, Jonathan G Yabes, Robert M Turner, Mina M Fam, Leonard J Appleman, Benjamin J Davies, Bruce L Jacobs Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Medicare | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Urology & Nephrology